<?xml version="1.0" encoding="UTF-8"?>
<p>One of the major problems in drug discovery and development is the poor pharmacokinetic profile of a drug candidate
 <xref rid="CIT0058" ref-type="bibr">
  <sup>58</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0059" ref-type="bibr">
  <sup>59</sup>
 </xref>. The success of a drug candidate to pass the clinical investigation depends mainly on its pharmacokinetic as well as pharmacodynamic profile. Accordingly, the 
 <italic>in silico</italic> studies of the physicochemical properties related to the pharmacokinetics of drug candidates have attracted considerable attention in the last two decades
 <xref rid="CIT0060" ref-type="bibr">
  <sup>60</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0061" ref-type="bibr">
  <sup>61</sup>
 </xref>.
</p>
